Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/luoxin-pharmaceuticals-lx-039-innovative-anti-tumor-drug-phase-i-clinical-study-data-presented-at-esmo-2023-301964360.html
https://www.prnewswire.com/news-releases/luoxin-pharmaceutical-signs-licensing-agreement-with-austria-based-marinomed-biotech-ag-for-budesolv-budesonide-nasal-spray-301405469.html
https://www.biospace.com/article/releases/luoxin-pharmaceutical-signs-licensing-agreement-with-austria-based-marinomed-biotech-ag-for-budesolv-budesonide-nasal-spray/?s=71
https://www.dgap.de/dgap/News/corporate/first-marinosolvr-platform-deal-marinomed-biotech-and-luoxin-pharmaceutical-group-stock-ltd-sign-agreement-budesolv-treat-allergic-rhinitis-greater-china/?newsID=1482231